Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors

Transplantation
Anthony J Langone, Peale Chuang

Abstract

Hyperlipidemia affects the majority of renal transplant patients. Multiple risk factors contribute to elevated serum cholesterol including the use of certain immunosuppressant agents. HMG-Co A reductase inhibitors have become the preferred class of cholesterol-lowering medication with an increasing body of evidence to support their safety, efficacy, and outcomes in both the normal and renal transplant populations. New guidelines recommend lowering previous LDL-c goals as outcomes appears to continually improve. As a result, ezetimibe has been added to patients with persistently elevated triglycerides and/or LDL-c in individuals who possessed a renal transplant and were deemed to be on a maximum safe dose of statin agent. After the addition of ezetimibe, total cholesterol, LDL-c, and triglycerides fell by 21%, 31%, and 13%, respectively. Creatinine phosphokinase, liver enzyme serum levels, and renal function were not affected to any level of clinical significance with the addition of ezetimibe. Large interpatient variability of measurable immunosuppressant levels was seen but no serious adverse events were attributed to a change in levels.

References

Mar 1, 1995·The Annals of Pharmacotherapy·C CampanaM Viganò
Feb 13, 2001·Clinical Transplantation·M F Carvalho, V Soares
Dec 31, 2002·Journal of the American College of Cardiology·Michael H DavidsonEnrico P Veltri
Feb 15, 2003·The American Journal of Cardiology·Boris KerznerUNKNOWN Ezetimibe Study Group
Nov 14, 2003·Journal of Managed Care Pharmacy : JMCP·Robert J Lipsy
Jan 7, 2005·The New England Journal of Medicine·Paul M RidkerUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Inv
Mar 25, 2005·The New England Journal of Medicine·Yann Loubières, Olivier Chereau
Apr 26, 2005·Transplantation Proceedings·J J PuthenparumpilB A Kiberd
May 6, 2005·Clinical Pharmacokinetics·Teddy KosoglouKevin B Alton
May 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Uwe PögeRainer P Woitas

❮ Previous
Next ❯

Citations

Apr 28, 2010·Journal of General Internal Medicine·Gaurav GuptaPeggy B Hasley
May 15, 2007·Transplantation·George Mells, James Neuberger
Nov 16, 2006·Expert Opinion on Therapeutic Targets·Irene F Gazi, Dimitri P Mikhailidis
Oct 29, 2011·Clinics in Liver Disease·R Todd StravitzDiane M Biskobing
Dec 23, 2008·Transplantation Proceedings·M L Rodríguez-Ferrero, F Anaya
Nov 18, 2008·Transplantation Proceedings·A Guisado RascoA Martínez Martínez
Nov 18, 2008·Transplantation Proceedings·M G Crespo-LeiroA Castro-Beiras
Mar 10, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Ayan R PatelDavid DeNofrio
May 22, 2008·Clinical Transplantation·Mathias H KonstandinThomas J Dengler
Jan 16, 2007·Alimentary Pharmacology & Therapeutics·A Sethi, R T Stravitz
Jul 6, 2012·Journal of the American College of Cardiology·Krista L LentineUNKNOWN American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Joseph Nogueira, Matthew Weir
Mar 12, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Ali OlyaeiJose Rueda
May 10, 2008·Postgraduate Medicine·Lisa R Tannock, L Raymond Reynolds
Nov 29, 2013·The Annals of Pharmacotherapy·Kathleen M MakkarSarah A Spinler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
C BuchananF Shihab
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
M KohnleO Witzke
© 2021 Meta ULC. All rights reserved